215 related articles for article (PubMed ID: 38037913)
1. Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds.
Zhong G; Wang X; Li J; Xie Z; Wu Q; Chen J; Wang Y; Chen Z; Cao X; Li T; Liu J; Wang Q
Curr Neuropharmacol; 2024; 22(10):1650-1671. PubMed ID: 38037913
[TBL] [Abstract][Full Text] [Related]
2. The Pivotal Role of Copper in Neurodegeneration: A New Strategy for the Therapy of Neurodegenerative Disorders.
Giampietro R; Spinelli F; Contino M; Colabufo NA
Mol Pharm; 2018 Mar; 15(3):808-820. PubMed ID: 29323501
[TBL] [Abstract][Full Text] [Related]
3. Copper Dyshomeostasis in Neurodegenerative Diseases-Therapeutic Implications.
Gromadzka G; Tarnacka B; Flaga A; Adamczyk A
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291628
[TBL] [Abstract][Full Text] [Related]
4. Chelating agents for neurodegenerative diseases.
Ward RJ; Dexter DT; Crichton RR
Curr Med Chem; 2012; 19(17):2760-72. PubMed ID: 22489724
[TBL] [Abstract][Full Text] [Related]
5. The transition metals copper and iron in neurodegenerative diseases.
Rivera-Mancía S; Pérez-Neri I; Ríos C; Tristán-López L; Rivera-Espinosa L; Montes S
Chem Biol Interact; 2010 Jul; 186(2):184-99. PubMed ID: 20399203
[TBL] [Abstract][Full Text] [Related]
6. Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics.
Davies KM; Mercer JF; Chen N; Double KL
Clin Sci (Lond); 2016 Apr; 130(8):565-74. PubMed ID: 26957644
[TBL] [Abstract][Full Text] [Related]
7. Repurposing of Copper(II)-chelating Drugs for the Treatment of Neurodegenerative Diseases.
Lanza V; Milardi D; Di Natale G; Pappalardo G
Curr Med Chem; 2018 Feb; 25(4):525-539. PubMed ID: 28521682
[TBL] [Abstract][Full Text] [Related]
8. The pivotal role of JAK/STAT and IRS/PI3K signaling pathways in neurodegenerative diseases: Mechanistic approaches to polyphenols and alkaloids.
Kooshki L; Zarneshan SN; Fakhri S; Moradi SZ; Echeverria J
Phytomedicine; 2023 Apr; 112():154686. PubMed ID: 36804755
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance.
Rossi L; Lombardo MF; Ciriolo MR; Rotilio G
Neurochem Res; 2004 Mar; 29(3):493-504. PubMed ID: 15038597
[TBL] [Abstract][Full Text] [Related]
10. The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications.
Perry G; Sayre LM; Atwood CS; Castellani RJ; Cash AD; Rottkamp CA; Smith MA
CNS Drugs; 2002; 16(5):339-52. PubMed ID: 11994023
[TBL] [Abstract][Full Text] [Related]
11. Current Biomedical Use of Copper Chelation Therapy.
Baldari S; Di Rocco G; Toietta G
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32041110
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptides: Roles and Activities as Metal Chelators in Neurodegenerative Diseases.
Ben-Shushan S; Miller Y
J Phys Chem B; 2021 Mar; 125(11):2796-2811. PubMed ID: 33570949
[TBL] [Abstract][Full Text] [Related]
13. Selective divalent copper chelation for the treatment of diabetes mellitus.
Cooper GJ
Curr Med Chem; 2012; 19(17):2828-60. PubMed ID: 22455587
[TBL] [Abstract][Full Text] [Related]
14. Use of Curcumin, a Natural Polyphenol for Targeting Molecular Pathways in Treating Age-Related Neurodegenerative Diseases.
Maiti P; Dunbar GL
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857538
[TBL] [Abstract][Full Text] [Related]
15. Metal-catalyzed disruption of membrane protein and lipid signaling in the pathogenesis of neurodegenerative disorders.
Mattson MP
Ann N Y Acad Sci; 2004 Mar; 1012():37-50. PubMed ID: 15105254
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
[TBL] [Abstract][Full Text] [Related]
17. Copper homeostasis and the ubiquitin proteasome system.
Zhang B; Burke R
Metallomics; 2023 Mar; 15(3):. PubMed ID: 36822629
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Autophagy in Neurodegenerative Diseases by Natural Products.
Liu S; Li X
Adv Exp Med Biol; 2020; 1207():725-730. PubMed ID: 32671789
[TBL] [Abstract][Full Text] [Related]
19. Copper-dependent oxidative stress and neurodegeneration.
Rotilio G; Carrì MT; Rossi L; Ciriolo MR
IUBMB Life; 2000; 50(4-5):309-14. PubMed ID: 11327325
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges.
Rahman MH; Bajgai J; Fadriquela A; Sharma S; Trinh TT; Akter R; Jeong YJ; Goh SH; Kim CS; Lee KJ
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]